ADVISORY, July 31, 2012 (GLOBE NEWSWIRE) -- What: Celgene Corporation [CELG] is an integrated global biopharmaceutical company that is changing the course of human health through bold pursuits in science for rare and debilitating diseases where unmet medical need is highest and the demand for innovative solutions is greatest. Our transformational science is delivering life-enhancing therapies that enable healthcare providers, worldwide, deliver better healthcare with better outcomes for patients in need. Celgene leadership will visit the NASDAQ MarketSite in Times Square.
